CME Group Inc. $CME Shares Sold by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. cut its position in CME Group Inc. (NASDAQ:CMEFree Report) by 22.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,533 shares of the financial services provider’s stock after selling 3,331 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in CME Group were worth $3,179,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently bought and sold shares of CME. Wayfinding Financial LLC acquired a new stake in CME Group in the first quarter valued at approximately $25,000. Webster Bank N. A. increased its holdings in CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after buying an additional 60 shares during the last quarter. Cornerstone Planning Group LLC increased its holdings in CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after buying an additional 55 shares during the last quarter. Highline Wealth Partners LLC raised its stake in CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 43 shares in the last quarter. Finally, Golden State Wealth Management LLC lifted its holdings in CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock worth $30,000 after buying an additional 98 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Down 1.8%

CME stock opened at $266.33 on Wednesday. The stock has a market capitalization of $95.98 billion, a PE ratio of 25.81, a price-to-earnings-growth ratio of 4.58 and a beta of 0.41. The company has a fifty day moving average of $266.38 and a 200-day moving average of $272.08. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a one year low of $213.94 and a one year high of $290.79.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The firm had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the business earned $2.68 earnings per share. The company’s revenue for the quarter was down 3.0% compared to the same quarter last year. As a group, analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s payout ratio is presently 48.45%.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on CME shares. Oppenheimer boosted their target price on CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a research note on Thursday, July 24th. Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft upgraded shares of CME Group from a “hold” rating to a “buy” rating and upped their target price for the company from $266.00 to $300.00 in a report on Thursday, October 23rd. JPMorgan Chase & Co. lifted their price target on shares of CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research note on Tuesday, October 14th. Finally, Jefferies Financial Group decreased their price objective on shares of CME Group from $313.00 to $304.00 and set a “buy” rating for the company in a research note on Friday, October 10th. Eight research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $284.53.

Read Our Latest Stock Analysis on CME

Insider Transactions at CME Group

In other CME Group news, Director William R. Shepard purchased 262 shares of the stock in a transaction on Thursday, September 25th. The stock was bought at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the acquisition, the director directly owned 258,459 shares of the company’s stock, valued at $68,540,742.21. This represents a 0.10% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 13,043 shares of company stock worth $3,527,956 over the last ninety days. 0.30% of the stock is currently owned by company insiders.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.